http://www.bostoncure.org:8080/article.pl?sid=03/10/20/1053258&mode=nested

Monday October 20
Stacey
Boston Cure Project

According to Crain's New York Business: "The Mount Sinai School of Medicine has been awarded a $30 million, five-year grant from the National Institute of Neurological Disorders and Stroke to conduct the first large-scale clinical trial of combination therapy for the degenerative disease multiple sclerosis. Currently, two drugs are used to treat the relapsing form of multiple sclerosis - interferon beta and glatiramer acetate. Both drugs only slow the progression of the incurable disease and both are expensive. The researchers, who will be led by Dr. Fred Lublin, director of Mount Sinai's Corinne Goldsmith Dickinson Center for Multiple Sclerosis, plan to design a national trial to see if the drugs work better together than they do separately."
 

Copyright © 2003, Boston Cure Project